Dr. Cornelia M. Wilson is a Reader and Academic Laboratory Director at Canterbury Christ Church University, specializing in molecular and cell biology. Her research focuses on cancer biology, neurodegenerative diseases, and the development of diagnostic and therapeutic strategies, including projects on lung cancer exosomes, exosome biogenesis in cancer, and targeting the NF-kB pathway. Since 2023, Dr. Wilson has led the Life Sciences Industry Liaison Lab at Discovery Park, UK, where she previously served as Senior Lecturer and Director (2016–2023). She played a pivotal role in establishing the lab and fostering industrial collaborations. Additionally, she held an honorary research position at the University of Liverpool and contributed to lung cancer research at the University of Limoges, France, where she established the first lung cancer biobank.